|
1
|
National Comprehensive Cancer Network®, .
NCCN Clinical Practice Guideline in Oncology (NCCN
Guideline®) Non-small cell lung cancer. https://www2.tri-kobe.org/nccn/guideline/lung/englishJune
10–2019
|
|
2
|
Goldstraw P, Chansky K, Crowley J,
Rami-Porta R, Asamura H, Eberhardt WE, Nicholson AG, Groome P,
Mitchell A, Bolejack V, et al: The IASLC lung cancer staging
project: Proposals for revision of the TNM stage groupings in the
forthcoming (Eighth) edition of the TNM classification for lung
cancer. J Thorac Oncol. 11:39–51. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim H, Goo JM, Kim YT and Park CM:
Consolidation-to-tumor ratio and tumor disappearance ratio are not
independent prognostic factors for the patients with resected lung
adenocarcinomas. Lung Cancer. 137:123–128. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hattori A, Hirayama S, Matsunaga T,
Hayashi T, Takamochi K, Oh S and Suzuki K: Distinct
clinicopathologic characteristics and prognosis based on the
presence of ground glass opacity component in clinical stage IA
lung adenocarcinoma. J Thorac Oncol. 14:265–275. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ye T, Deng L, Wang S, Xiang J, Zhang Y, Hu
H, Sun Y, Li Y, Shen L, Xie L, et al: Lung adenocarcinomas
manifesting as radiological part-solid nodules define a special
clinical subtype. J Thorac Oncol. 14:617–627. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Miyoshi T, Aokage K, Katsumata S, Tane K,
Ishii G and Tsuboi M: Ground-glass opacity is a strong
prognosticator for pathologic stage IA lung adenocarcinoma. Ann
Thorac Surg. 108:249–255. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fischer B, Lassen U, Mortensen J, Larsen
S, Loft A, Bertelsen A, Ravn J, Clementsen P, Høgholm A, Larsen K,
et al: Preoperative staging of lung cancer with combined PET-CT. N
Engl J Med. 361:32–39. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
The Japan Lung Cancer Society, . Japanese
guideline for lung cancer treatment. https://www.haigan.gr.jp/guideline/2018/1/1/180101050100.htmlJune
10–2019
|
|
9
|
Shirai K, Abe T, Saitoh JI, Mizukami T,
Irie D, Takakusagi Y, Shiba S, Okano N, Ebara T, Ohno T and Nakano
T: Maximum standardized uptake value on FDG-PET predicts survival
in stage I non-small cell lung cancer following carbon ion
radiotherapy. Oncol Lett. 13:4420–4426. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li L, Ren S, Zhang Y, Guan Y, Zhao J, Liu
J, Wang Q, Chen G, Chen H, Xiang J and Fu X: Risk factors for
predicting the occult nodal metastasis in T1-2N0M0 NSCLC patients
staged by PET/CT: Potential value in the clinic. Lung Cancer.
81:213–217. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kaseda K, Asakura K, Kazama A and Ozawa Y:
Risk factors for predicting occult lymph node metastasis in
patients with clinical stage I non-small cell lung cancer staged by
integrated fluorodeoxyglucose positron emission tomography/computed
tomography. World J Surg. 40:2976–2983. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nakada T and Kuroda H: Narrative review of
optimal prognostic radiological tools using computed tomography for
T1N0-staged non-small cell lung cancer. J Thorac Dis. 13:3171–3181.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hishida T, Miyaoka E, Yokoi K, Tsuboi M,
Asamura H, Kiura K, Takahashi K, Dosaka-Akita H, Kobayashi H, Date
H, et al: Lobe-specific nodal dissection for clinical stage I and
II NSCLC: Japanese multi-institutional retrospective study using a
propensity score analysis. J Thorac Oncol. 11:1529–1537. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hattori A, Suzuki K, Takamochi K,
Wakabayashi M, Aokage K, Saji H and Watanabe SI; Japan Clinical
Oncology Group Lung Cancer Surgical Study Group, : Prognostic
impact of a ground-glass opacity component in clinical stage IA
non-small cell lung cancer. J Thorac Cardiovasc Surg.
161:1469–1480. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Suzuki K, Watanabe SI, Wakabayashi M, Saji
H, Aokage K, Moriya Y, Yoshino I, Tsuboi M, Nakamura S, Nakamura K,
et al: A single-arm study of sublobar resection for ground-glass
opacity dominant peripheral lung cancer. J Thorac Cardiovasc Surg.
163:289–301.e2. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hattori A, Matsunaga T, Takamochi K, Oh S
and Suzuki K: Clinical significance of positron emission tomography
in subcentimeter non-small cell lung cancer. Ann Thorac Surg.
103:1614–1620. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kuroda H, Nakada T, Oya Y, Takahashi Y,
Matsusita H and Sakakura N: Clinical adjustability of radiological
tools in patients with surgically resected cT1N0-staged
non-small-cell lung cancer from the long-term survival evaluation.
J Thorac Dis. 12:6655–6662. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim H, Goo JM, Kim YT and Park CM:
Validation of the eighth edition clinical T categorization system
for clinical stage IA, resected lung adenocarcinomas: Prognostic
implications of the ground-glass opacity component. J Thorac Oncol.
15:580–588. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chiang XH, Hsu HH, Hsieh MS, Chang CH,
Tsai TM, Liao HC, Tsou KC, Lin MW and Chen JS: Propensity-matched
analysis comparing survival after sublobar resection and lobectomy
for cT1N0 LUNG ADENOCARCINoma. Ann Surg Oncol. 27:703–715. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Su H, Dai C, She Y, Ren Y, Zhang L, Xie H,
Xie D, Jiang G and Chen C: Which T descriptor is more predictive of
recurrence after sublobar resection: Whole tumour size versus solid
component size? Eur J Cardiothorac Surg. 54:1028–1036. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hattori A, Matsunaga T, Takamochi K, Oh S
and Suzuki K: Importance of ground glass opacity component in
clinical stage IA radiologic invasive lung cancer. Ann Thorac Surg.
104:313–320. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Takenaka T, Yamazaki K, Miura N, Mori R
and Takeo S: The prognostic impact of tumor volume in patients with
clinical stage IA non-small cell lung cancer. J Thorac Oncol.
11:1074–1080. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fu F, Zhang Y, Wen Z, Zheng D, Gao Z, Han
H, Deng L, Wang S, Liu Q, Li Y, et al: Distinct prognostic factors
in patients with stage I non-small cell lung cancer with radiologic
part-solid or solid lesions. J Thorac Oncol. 14:2133–2142. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Travis WD, Brambilla E, Noguchi M,
Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ,
Van Schil PE, et al: International association for the study of
lung cancer/american thoracic society/european respiratory society
international multidisciplinary classification of lung
adenocarcinoma. J Thorac Oncol. 6:44–285. 2011. View Article : Google Scholar
|
|
25
|
Hayashi H, Ashizawa K, Ogihara Y, Nishida
A, Matsumoto K, Yamasaki N, Nagayasu T, Fukuda M, Honda S and
Uetani M: Comparison between solid component size on thin-section
CT and pathologic lymph node metastasis and local invasion in T1
lung adenocarcinoma. Jpn J Radiol. 35:109–115. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sakakura N, Inaba Y, Yatabe Y, Mizuno T,
Kuroda H, Yoshimura K and Sakao Y: Estimation of the pathological
invasive size of pulmonary adenocarcinoma using high-resolution
computed tomography of the chest: A consideration based on lung and
mediastinal window settings. Lung Cancer. 95:51–56. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Taira N, Atsumi E, Nakachi S, Takamatsu R,
Yohena T, Kawasaki H, Kawabata T and Yoshimi N: Comparison of
GLUT-1, SGLT-1, and SGLT-2 expression in false-negative and
true-positive lymph nodes during the 18F-FDG PET/CT
mediastinal nodal staging of non-small cell lung cancer. Lung
Cancer. 123:30–35. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Park HK, Jeon K, Koh WJ, Suh GY, Kim H,
Kwon OJ, Chung MP, Lee KS, Shim YM, Han J and Um SW: Occult nodal
metastasis in patients with non-small cell lung cancer at clinical
stage IA by PET/CT. Respirology. 15:1179–1184. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nambu A, Kato S, Sato Y, Okuwaki H,
Nishikawa K, Saito A, Matsumoto K, Ichikawa T and Araki T:
Relationship between maximum standardized uptake value (SUVmax) of
lung cancer and lymph node metastasis on FDG-PET. Ann Nucl Med.
23:269–275. 2009. View Article : Google Scholar : PubMed/NCBI
|
